Age-specific mortality risk from pandemic influenza

Journal of Theoretical Biology

Volumn 288, Issue 1, 2011, Pages 29-34

  Ma, Junling ^a   Dushoff, Jonathan ^b,c   Earn, David J D ^b,c  

^a UNIVERSITY OF VICTORIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

1918; 1957; 1968; Antigenic imprinting; Cytokine storm; Original antigenic sin; Pandemic influenza

Indexed keywords

AGE STRUCTURE; ANTIGEN; DATABASE; EPIDEMIC; IMMUNITY; INFLUENZA; MORTALITY RISK; VIRULENCE;

ADAPTIVE IMMUNITY; ADULT; AGE DISTRIBUTION; ANTIGENICITY; ARTICLE; CANADA; CAUSE OF DEATH; CONTROLLED STUDY; CYTOKINE STORM; HUMAN; IMMUNE RESPONSE; MORTALITY; PANDEMIC INFLUENZA; PNEUMONIA; POPULATION SIZE; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION; VIRUS VIRULENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CANADA; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMANS; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; MORTALITY; ORTHOMYXOVIRIDAE; PANDEMICS; RISK ASSESSMENT; YOUNG ADULT;

CANADA;

EID: 80052094418     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2011.08.003     Document Type: Article

References (41)

1. Andreasen V., Viboud C., Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. Journal of Infectious Diseases 2008, 197:270-278.
2. Bansal S., Pourbohloul B., Hupert N., Owen R., Irving D., et al. The shifting demographic landscape of pandemic influenza. PLoS ONE 2010, 5:e9360.
3. Butler D. Swine flu goes global. Nature 2009, 458:1082-1083.
4. Chowell G., Bertozzi S.M., Colchero M.A., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. New England Journal of Medicine 2009, 361:674-679.
5. Cohen J., Enserink M. As swine flu circles globe, scientists grapple with basic questions. Science 2009, 324:572-573.
6. Davenport F.M., Hennessy A.V., Francis J.T. Epidemiological and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. Journal of Experimental Medicine 1953, 98:641.
7. Dushoff J., Plotkin J.B., Viboud C., Earn D.J.D., Simonsen L. Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. American Journal of Epidemiology 2006, 163:181-187.
8. Earn D.J.D., Dushoff J., Levin S.A. Ecology and evolution of the flu. TRENDS in Ecology and Evolution 2002, 17:334-340.
9. Fazekas de StGroth S., Webster R.G. Disquisitions on original antigenic sin: I. Evidence in man. Journal of Experimental Medicine 1966, 124:331-345.
10. Ferrara J.L.M., Abhyankar S., Gilliland D.G. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplantation Proceedings 1993, 25:1216-1217.
11. Francis J.T. Influenza: the newe acquayantance. Annals of Internal Medicine 1953, 39:203-221.
12. Francis J.T. The current status of the control of influenza. Annals of Internal Medicine 1955, 43:534-538.
13. Francis J.T. On the doctrine of original antigenic sin. Proceedings of the American Philosophical Society 1960, 104:572-578.
14. Francis J.T., Davenport F.M., Hennessy A.V. A serological recapitulation of human infection with different strains of influenza virus. Transactions of the Association of American Physicians 1953, 66:231-239.
15. Glezen W.P. Emerging infections: pandemic influenza. Epidemiologic Reviews 1996, 18:64-76.
16. Hayashida H., Toh H., Kikuno R., Miyata T. Evolution of influenza virus genes. Molecular Biology and Evolution 1985, 2:289-303.
17. Hope-Simpson, R.E., 1992. The Transmission of Epidemic Influenza. Plenum Press, New York.
18. Huang K.J., Su I.J., Theron M., et al. An interferon-g-related cytokine storm in SARS patients. Journal of Medical Virology 2005, 75:185-194.
19. Kobasa D., Takada A., Shinya K., et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004, 431:703-707.
20. Lipsitch M., Riley S., Cauchemez S., Ghani A.C., Ferguson N.M. Managing and reducing uncertainty in an emerging influenza pandemic. New England Journal of Medicine 2009, 361:112.
21. Loeb M., Russell ML., Moss L., Fonseca K., Fox J., et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA-Journal of the American Medical Association 2010, 303:943-950.
22. Longini I.M., Halloran M.E. Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology 2005, 161:303-306.
23. McVernon J., Laurie K., Nolan T., et al. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors. Euro surveillance 2009, 15:19678.
24. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375:1100-1108.
25. Morens D.M., Fauci A.S. The 1918 influenza pandemic: insights for the 21st century. Journal of Infectious Diseases 2007, 195:1018-1028.
26. Mulder J., Masurel N. Pre-epidemic antibody against 1957 strain of asiatic influenza in serum of older people living in the Netherlands. Lancet 1958, 1:810-814.
27. Nakajima K., Desselberger U., Palese P. Recent human influenza A (H1N1) viruses are closely related to strains isolated in 1950. Nature 1978, 274:334-339.
28. Olson D.R., Simonsen L., Edelson P.J., Morse S.S. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proceedings of the National Academy of Sciences of the United States 2005, 102:11059-11063.
29. Osterholm M.T. Preparing for the next pandemic. New England Journal of Medicine 2005, 352:18.
30. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., et al. The Japanese experience with vaccinating schoolchildren against influenza. New England Journal of Medicine 2001, 344:889-896.
31. Serfling R.E. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Report 1963, 78:494-506.
32. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of Infectious Diseases 1998, 178:53-60.
33. Simonsen L., Reichertb T.A., Miller M.A. The virtues of antigenic sin: consequences of pandemic recycling on influenza-associated mortality. International Congress Series 2004, 1263:791-794.
34. Smith D.J., Lapedes A.S., de Jong J.C., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
35. Statistics Canada, 1956. Population, Age Groups, 1956 Census. Ottawa, Ontario: Statistics Canada Catalogue no. 92-509.
36. Statistics Canada, 1966. Population, Age Groups, 1966 Census. Ottawa, Ontario: Statistics Canada Catalogue no. 92-611.
37. Szretter K.J., Gangappa S., Lu X., et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. Journal of Virology 2007, 81:2736-2744.
38. Taubenberger J.K., Morens D.M. 1918 influenza: the mother of all pandemics. Emerging Infectious Diseases 2006, 12:15-22.
39. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003, 289:179-186.
40. United States Bureau of the Census, 1937-1992. Vital Statistics of the United States. Government Printing Office, Washington, DC.
41. United States Bureau of the Census, 1920. Census of Population and Housing, 1920 Census, vol. 2. Government Printing Office. Chapter III, p. 154. http://www.census.gov/prod/www/abs/decennial/1920.htm.